It’s now been a year since contaminated injectable products were linked to patient illness and death. The spotlight on pharmacy and compounding has been harsh in the ensuing months, but I am proud of the way our profession acknowledged the need for improvements, and worked closely together with federal and state policy makers toward positive change.
At APhA, the focus on pharmaceutical compounding began the day CDC announced a possible association between illnesses and products from the New England Compounding Center (NECC). We immediately launched ourJust the Facts: Compounding page on pharmacist.com to keep our members informed and began populating it withFrequently Asked Questions, news stories, profiles that explained why patients need pharmacists’ compounding services, and CEO blog posts. Many of the compounding-related articles and blog posts published this past year are listed below.